​
​

Applied Therapeutics (APLT) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Applied Therapeutics Revenue Highlights

Latest Revenue (Y)

$9.99M

Latest Revenue (Q)

$144.00K

Main Segment (Y)

License

Applied Therapeutics Revenue by Period

Applied Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Applied Therapeutics generated $9.99M in revenue during NA 2023, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Applied Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30--24.21%
2024-03-31--128.49%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Applied Therapeutics generated $144.00K in revenue during Q2 2024, up -24.21% compared to the previous quarter, and up 1.35% compared to the same period a year ago.

Applied Therapeutics Revenue Breakdown

Applied Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
License-
Research and Development Services-

Applied Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (92.25%), and Research and Development Services (7.75%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24
Research and Development Services--

Applied Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Research and Development Services (100.00%).

Applied Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
HOOKHOOKIPA Pharma--
SEERSeer--
APLTApplied Therapeutics--
MOLNMolecular Partners--
STTKShattuck Labs--
LYRALyra Therapeutics--
TFFPTFF Pharmaceuticals--
LIFEaTyr Pharma--
GANXGain Therapeutics--
ANEBAnebulo Pharmaceuticals--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
XFORX4 Pharmaceuticals--
BCABBioAtla--
DAWNDay One Biopharmaceuticals--
INABIN8bio--
TERNTerns Pharmaceuticals--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
VINCVincerx Pharma--
ORICORIC Pharmaceuticals--
LTRNLantern Pharma--

APLT Revenue FAQ

What is Applied Therapeutics’s yearly revenue?

Applied Therapeutics's yearly revenue for 2023 was $9.99M, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. APLT's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Applied Therapeutics’s quarterly revenue?

Applied Therapeutics's quarterly revenue for Q2 2024 was $144K, a -24.21% decrease from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $190K, a -128.49% decrease from the previous quarter (Q4 2023), and a -98.22% decrease year-over-year (Q1 2023). APLT's quarterly revenue for Q4 2023 was $-667K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Applied Therapeutics’s revenue growth rate?

Applied Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.

What are Applied Therapeutics’s revenue streams?

Applied Therapeutics's revenue streams in c 23 are License, and Research and Development Services. License generated $9.22M in revenue, accounting 92.25% of the company's total revenue Research and Development Services generated $774K in revenue, accounting 7.75% of the company's total revenue

What is Applied Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Applied Therapeutics was License. This segment made a revenue of $9.22M, representing 92.25% of the company's total revenue.